tiprankstipranks
Advertisement
Advertisement

PCDISCU Stock Latest News

Discure Technologies Ltd – Weekly Recap
Private CompaniesDiscure Technologies Ltd – Weekly Recap
4M ago
DISCU
Discure Technologies Gains FDA TAP Program Acceptance for Degenerative Disc Disease Therapy
PremiumPrivate Companies
Discure Technologies Gains FDA TAP Program Acceptance for Degenerative Disc Disease Therapy
4M ago
DISCU
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Signals Encouraging Early Results
PremiumPrivate Companies
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Signals Encouraging Early Results
4M ago
DISCU
Discure Technologies Advances Toward Pivotal U.S. Trial for Chronic Back Pain Therapy
PremiumPrivate Companies
Discure Technologies Advances Toward Pivotal U.S. Trial for Chronic Back Pain Therapy
4M ago
DISCU
Discure Technologies Enters FDA TAP Program, Advancing Degenerative Disc Disease Therapy
PremiumPrivate Companies
Discure Technologies Enters FDA TAP Program, Advancing Degenerative Disc Disease Therapy
4M ago
DISCU
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Plans to Reveal Early Data at Major Spine Conferences
PremiumPrivate CompaniesDiscure Technologies Completes Enrollment in First-in-Human Clinical Study, Plans to Reveal Early Data at Major Spine Conferences
4M ago
DISCU
Discure Technologies Advances Toward Pivotal U.S. Trial in Chronic Back Pain
Premium
Private Companies
Discure Technologies Advances Toward Pivotal U.S. Trial in Chronic Back Pain
4M ago
DISCU
Discure Technologies Joins FDA TAP Program and Advances First-in-Human Study for Degenerative Disc Disease
Premium
Private Companies
Discure Technologies Joins FDA TAP Program and Advances First-in-Human Study for Degenerative Disc Disease
4M ago
DISCU
Discure Technologies Completes Enrollment in First-in-Human Clinical Study
PremiumPrivate Companies
Discure Technologies Completes Enrollment in First-in-Human Clinical Study
4M ago
DISCU
Discure Technologies Prepares for Pivotal U.S. Trial and Expands Clinical Leadership
PremiumPrivate Companies
Discure Technologies Prepares for Pivotal U.S. Trial and Expands Clinical Leadership
4M ago
DISCU
Discure Technologies Joins FDA TAP Program as First-in-Human Trial Progresses
PremiumPrivate Companies
Discure Technologies Joins FDA TAP Program as First-in-Human Trial Progresses
4M ago
DISCU
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Eyes Key 2025 Data Milestones
PremiumPrivate Companies
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Eyes Key 2025 Data Milestones
4M ago
DISCU
Discure Technologies Prepares for Pivotal U.S. Trial in Chronic Back Pain, Expands Clinical Leadership
PremiumPrivate CompaniesDiscure Technologies Prepares for Pivotal U.S. Trial in Chronic Back Pain, Expands Clinical Leadership
4M ago
DISCU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >